My ePortfolio Register   

AACR 2014 /
Immunotherapy in melanoma

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.05.14
Views: 2058

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

Dr Daud talks to ecancertv at the AACR conference about his work with immunotherapy in melanoma, specifically the PD-1 pathway and how, when disabled, cancer cells are prevented from penetrating further.

Read the article for more.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence